262 results

 A model of Covid-19, known as coronavirus, is seen ahead  during a US Senate Appropriations subcommittee hearing on the plan to research, manufacture and distribute a coronavirus vaccine. Photograph: Saul Loeb-Pool/Getty Images

The remarkable global effort to produce a range of Covid-19 vaccines in parallel with developing new treatments – many of which are adapting proven me(...)

In the clinical study, 24 people between the ages of 18 and 55 who received two doses of the vaccine had “significantly elevated” antibodies within four weeks of their first injection. Photograph: iStock

A coronavirus vaccine from Germany’s BioNTech has yielded positive trial results, generating immune defences in participants that were stronger than t(...)

France president Emmanuel Macron visits drugmaker Sanofi’s vaccine unit in Marcy-l’Etoile, near Lyon.

French drugmaker Sanofi said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain’s GlaxoSmithKline (...)

The S&P 500 and the Dow were largely unchanged on Thursday as investors stayed on the sidelines amid an uptick in coronavirus infections in parts of the United States and an elevated level of weekly jobless claims.  Photograph:  Timothy  Clary/AFP via Getty Images

European shares closed lower on Thursday as a spike in Covid-19 cases in China and some US states triggered fears of a second wave of infections. And (...)

Staff at  the Institute of Virology at the University in Marburg, Germany, where work on a Covid-19 vaccine is taking place.  Photograph: Ronald Wittek/EPA

The European Union has laid out plans to place advance orders for coronavirus vaccines currently under development to ensure supplies for member state(...)

Stay-at-home stocks such as video conferencing platform Zoom Video Communications fell in value after surging during lockdowns. Photograph: Albert Gea/Reuters

European shares pulled back from three-month highs on Monday, with losses in technology and healthcare stocks halting a recent rally on hopes of a pos(...)

European shares retreated from three-month highs on Monday, as investors locked in some profits following a strong rally last week on hopes of a post-(...)

Gilead Sciences is headquarters in  California, US. Photograph: Justin Sullivan/Getty Images

Shares of Gilead Sciences rose as much as 3 per cent on Monday after a report said the US drugmaker had been approached by Britain’s AstraZeneca for (...)

AstraZeneca:  An unspecified part of the vaccine doses produced by Serum will be used in India.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to two billion doses in two deals involving Mic(...)

US stocks rose to a 12-week high as data showed the economic damage from the coronavirus pandemic was less severe than anticipated. Photograph: Spencer Platt/Getty Images

European shares rose for a fourth straight session on Thursday, as optimism over businesses returning to work and stimulus for the battered euro-zone (...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »